文献速递中枢神经肿瘤放疗放疗物理与技术

最小化几何不确定性与摆位误差可改善颅内立体定向放射外科的肿瘤控制

Minimization of Geometric Uncertainties and Setup Errors Improves Tumor Control for Intracranial Stereotactic Radiosurgery.
PubMed 文献 · Adv Radiat Oncol · 2026-03-31

该回顾性研究分析50例患者75个脑转移灶的直线加速器SRS,模拟1-2mm几何不确定性对TCP的影响。肿瘤大小调节几何不确定性的影响:≤20mm病灶剂量梯度更陡、剂量下降更大,但初始TCP高故TCP下降幅度有限;>20mm病灶初始TCP较低且位于剂量反应曲线陡峭段,相同或更小剂量损失导致TCP显著下降。结论提示大肿瘤患者对几何不确定性最易出现肿瘤控制损失。

要点

  • ≤20mm脑转移灶剂量梯度更陡(梯度指数3.6 vs 2.6,P=.001),2mm位移下GTV D100%下降更大(中位4.5Gy vs 3.3Gy,P<.001)。
  • ≤20mm病灶初始TCP高(中位96.6%),TCP下降幅度有限(中位3.4%)。
  • >20mm病灶初始TCP较低(中位82.1%),2mm位移下TCP下降显著(中位10.9%,P<.001),1mm位移下ΔTCP 3.5% vs 1.0%。

核心结论

  • 大肿瘤(>20mm)患者可能最易因SRS几何不确定性出现显著肿瘤控制损失。
  • 分析支持从固定PTV外扩转向基于肿瘤大小和放射生物学特征的分次放疗策略。

研究设计与样本

  • 回顾性分析50例接受直线加速器SRS患者的75个脑转移灶。
  • 通过给治疗计划施加位置偏移模拟几何不确定性,量化TCP下降。
  • 比较≤20mm与>20mm肿瘤的剂量学和放射生物学特征。

主要发现

  • 肿瘤大小调节几何不确定性的影响:≤20mm病灶剂量梯度更陡(梯度指数3.6 vs 2.6,P=.001)。
  • 2mm位移下≤20mm病灶GTV D100%下降中位4.5Gy,>20mm病灶中位3.3Gy(P<.001)。
  • ≤20mm病灶初始TCP中位96.6%,TCP下降中位3.4%;>20mm病灶初始TCP中位82.1%,2mm位移下TCP下降中位10.9%(P<.001)。
  • 1mm位移下ΔTCP为3.5% vs 1.0%。

关键数值与推荐

  • 假设均匀2mm PTV外扩。
  • 小病灶(≤20mm)梯度指数3.6 vs 大病灶2.6(P=.001)。
  • 2mm位移下GTV D100%下降中位4.5Gy vs 3.3Gy(P<.001)。
  • ≤20mm病灶初始TCP中位96.6%,TCP下降中位3.4%;>20mm病灶初始TCP中位82.1%,TCP下降中位10.9%(P<.001)。

临床怎么用

  • 对>20mm脑转移灶行SRS时应特别关注几何不确定性和摆位误差的最小化。
  • 可考虑根据肿瘤大小和放射生物学特征个体化选择分次立体定向放疗。

局限性

  • 本研究为假设生成性研究,需外部验证。
  • 分次立体定向放疗是未来研究主题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the lesion-level effect of 1-2-mm geometric uncertainty on tumor control probability (TCP) in brain-metastasis stereotactic radiosurgery (SRS), assuming a uniform 2-mm planning target volume margin. METHODS AND MATERIALS: We retrospectively analyzed 75 brain metastases in 50 patients who underwent linear accelerator-based SRS. Geometric uncertainty was simulated by applying positional shifts to the treatment plan, and the resulting reduction in TCP was quantified. The resulting dosimetric and radiobiological characteristics were compared between tumors ≤20 mm and those >20 mm. RESULTS: Tumor size modulated the impact of geometric uncertainty. Small lesions (≤20 mm) exhibited steeper dose gradients (gradient index, 3.6 vs 2.6; P = .001) and therefore larger reductions in gross tumor volume D100% under a 2-mm shift (median, 4.5 Gy vs 3.3 Gy; P < .001). However, because their initial TCP was high (median 96.6%), the TCP decrement remained modest (median 3.4%). In contrast, large lesions (>20 mm) began with a lower TCP (median 82.1%) and lay on the steep portion of the dose-response curve, so similar or smaller dose losses produced a substantially greater TCP decline (median 10.9% at 2 mm; P < .001). The same pattern was observed with 1-mm shifts (ΔTCP 3.5% vs 1.0%). CONCLUSIONS: Patients with larger tumors (>20 mm) may be most vulnerable to a significant loss of tumor control from geometric uncertainties in SRS. This analysis shows promise for personalizing treatment delivery, supporting a shift from applying fixed planning target volume margins toward strategies such as fractionated radiation therapy tailored to individual tumor size and radiobiological characteristics. This hypothesis-generating study requires external validation, with fractionated stereotactic radiation therapy being a subject for future investigation.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Suzuki T, Tachibana H, Takahashi Y, et al. Minimization of Geometric Uncertainties and Setup Errors Improves Tumor Control for Intracranial Stereotactic Radiosurgery. Adv Radiat Oncol. 2026. PMID: 42222509. doi:10.1016/j.adro.2026.102047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。